4.7 Article

Crosstalk between CLCb/Dyn1-Mediated Adaptive Clathrin-Mediated Endocytosis and Epidermal Growth Factor Receptor Signaling Increases Metastasis

Journal

DEVELOPMENTAL CELL
Volume 40, Issue 3, Pages 278-288

Publisher

CELL PRESS
DOI: 10.1016/j.devcel.2017.01.007

Keywords

-

Funding

  1. National Cancer Institute of the NIH [5P30CA142543]
  2. Texas Institute for Brain Injury and Repair (TIBIR)
  3. NIH [R01 GM73165, MH61345, GM42455]
  4. Taiwan National Science Council [103-2917-I-564-029]

Ask authors/readers for more resources

Signaling receptors are internalized and regulated by clathrin-mediated endocytosis (CME). Two clathrin light chain isoforms, CLCa and CLCb, are integral components of the endocytic machinery whose differential functions remain unknown. We report that CLCb is specifically upregulated in non-small-cell lung cancer (NSCLC) cells and is associated with poor patient prognosis. Engineered single CLCb-expressing NSCLC cells, as well as switched cells that predominantly express CLCb, exhibit increased rates of CME and altered clathrin-coated pit dynamics. This adaptive CME resulted from up regulation of dynamin-1 (Dyn1) and its activation through a positive feedback loop involving enhanced epidermal growth factor (EGF)-dependent Akt/GSK3 beta phosphorylation. CLCb/Dyn1-dependent adaptive CME selectively altered EGF receptor trafficking, enhanced cell migration in vitro, and increased the metastatic efficiency of NSCLC cells in vivo. We define molecular mechanisms for adaptive CME in cancer cells and a role for the reciprocal crosstalk between signaling and CME in cancer progression.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available